Niall Anderson

Person

  • Stevenage, GB

Patents Grantslast 30 patents

  • Information Patent Grant

    Heterocyclic amides as kinase inhibitors

    • Patent number 11,485,710
    • Issue date Nov 1, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Heterocyclic amides as kinase inhibitors

    • Patent number 10,899,716
    • Issue date Jan 26, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Chemical compounds

    • Patent number 10,793,559
    • Issue date Oct 6, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Heterocyclic amides as kinase inhibitors

    • Patent number 10,590,085
    • Issue date Mar 17, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Naphthyridine derivatives as alpha V beta 6 integrin antagonists fo...

    • Patent number 10,513,517
    • Issue date Dec 24, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Naphthyridines as integrin antagonists

    • Patent number 10,487,080
    • Issue date Nov 26, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Chemical compounds

    • Patent number 10,457,674
    • Issue date Oct 29, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagon...

    • Patent number 10,450,312
    • Issue date Oct 22, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds αvβ6 integrin antagonists

    • Patent number 10,342,783
    • Issue date Jul 9, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Naphthyridine derivatives as alpha v beta 6 integrin antagonists fo...

    • Patent number 10,144,733
    • Issue date Dec 4, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Naphthyridine derivatives useful as αvβ6 integrin antagonists

    • Patent number 10,023,568
    • Issue date Jul 17, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds alpha v beta 6 integrin antagonists

    • Patent number 10,004,724
    • Issue date Jun 26, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds αvβ6 integrin antagonists

    • Patent number 10,000,489
    • Issue date Jun 19, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds αv β6 integrin antagonists

    • Patent number 9,956,209
    • Issue date May 1, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    HETEROCYCLIC AMIDES AS KINASE INHIBITORS

    • Publication number 20230120185
    • Publication date Apr 20, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Heterocyclic Amides as Kinase Inhibitors

    • Publication number 20210253532
    • Publication date Aug 19, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS

    • Publication number 20210206758
    • Publication date Jul 8, 2021
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HETEROCYCLIC AMIDES AS KINASE INHIBITORS

    • Publication number 20200165205
    • Publication date May 28, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CHEMICAL COMPOUNDS

    • Publication number 20200071311
    • Publication date Mar 5, 2020
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS.

    • Publication number 20190275016
    • Publication date Sep 12, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS

    • Publication number 20190112306
    • Publication date Apr 18, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FO...

    • Publication number 20190048005
    • Publication date Feb 14, 2019
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CHEMICAL COMPOUNDS

    • Publication number 20190040051
    • Publication date Feb 7, 2019
    • Niall Andrew ANDERSON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGON...

    • Publication number 20180291022
    • Publication date Oct 11, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

    • Publication number 20180271845
    • Publication date Sep 27, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HETEROCYCLIC AMIDES AS KINASE INHIBITORS

    • Publication number 20180134665
    • Publication date May 17, 2018
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

    • Publication number 20170298063
    • Publication date Oct 19, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

    • Publication number 20170290817
    • Publication date Oct 12, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

    • Publication number 20170290818
    • Publication date Oct 12, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FO...

    • Publication number 20170291899
    • Publication date Oct 12, 2017
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew ANDERSON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGON...

    • Publication number 20160280705
    • Publication date Sep 29, 2016
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CATHEPSIN C INHIBITORS

    • Publication number 20120142668
    • Publication date Jun 7, 2012
    • Niall Anderson
    • C07 - ORGANIC CHEMISTRY